Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNIP1 antisense RNA 1 (KCNIP1-AS1)
- Target
- KCNIP1-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Natural antisense transcript (NAT), Other
01
Overview
KCNIP1 antisense RNA 1 (KCNIP1-AS1) is a long noncoding antisense RNA transcribed from the genomic region overlapping the KCNIP1 gene. KCNIP1-AS1 is categorized as a natural antisense transcript (NAT), and although its specific function is not characterized, similar NATs are known to regulate the expression and splicing of their sense gene counterparts through a range of transcriptional and post-transcriptional mechanisms. The sense gene, KCNIP1, encodes a calcium-binding protein that modulates voltage-gated potassium channels, and is functionally relevant in neuronal excitability and cardiac conduction[1][4]. NATs like KCNIP1-AS1 may influence these processes by modulating KCNIP1 transcript levels or processing. No data are currently available regarding direct involvement in disease, biomarker utility, or drug interaction.
- Other names
- CTC-265N9.1KCNIP1-AS1
02
Mechanism of action
None described for drugs targeting this molecule. For NATs generally, antisense oligonucleotides (ASOs) can modulate NAT expression to influence disease-relevant sense gene expression[3].
03
Biological functions
Regulation of gene expression (through sense-antisense RNA interaction at transcriptional or post-transcriptional levels)Epigenetic regulation (potentially modulating chromatin state or gene imprinting)Other
04
Disease associations
Neurodegenerative disease (KCNIP1 is implicated in neuronal excitability, which suggests related NATs may have neurological relevance)Cardiovascular disease (KCNIP1 is linked to Arrhythmia/Atrial Fibrillation)Other
Beyond the preview
Go deeper on KCNIP1 antisense RNA 1 (KCNIP1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KCNIP1 antisense RNA 1 (KCNIP1-AS1).